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A B S T R A C T
It is well known that the eﬃcacy of a single oral dose of benzimidazoles against Trichuris spp. infections in
humans and animals is poor, but is currently still used in control programmes against human trichuriasis.
However, the route of the benzimidazoles from the treated host to Trichuris remains unknown. As parts of adult
Trichuris are situated intracellularly in the caecum, they might be exposed to anthelmintic drugs in the intestinal
content as well as the mucosa. In this study, the pathway of oxfendazole and its metabolites was explored using a
T. suis-pig infection model, by simultaneously measuring drug concentrations within the worms and the caecal
mucosa, caecal tissue, caecal content and plasma of pigs over time after a single oral dose of 5 mg/kg oxfen-
dazole. Additionally, for comparison to the in vivo study, drug uptake and metabolism of oxfendazole by T. suis
was examined after in vitro incubation. Oxfendazole and metabolites were quantiﬁed by High Performance
Liquid Chromatography.
Multivariate linear regression analysis showed a strong and highly signiﬁcant association between OFZ
concentrations within T. suis and in plasma, along with a weaker association between OFZ concentrations in
caecal tissue/mucosa and T. suis, suggesting that oxfendazole reaches T. suis after absorption from the gastro-
intestinal tract and enters the worms by the blood-enterocyte pathway. The fenbendazole sulfone level in T. suis
was highly aﬀected by the concentrations in plasma. In addition, correlations between drug concentrations in the
host compartments, were generally highest for this metabolite. In comparison to oxfendazole, the correlation
between plasma and content was particularly high for this metabolite, suggesting a high level of drug movement
between these compartments and the possible involvement of the enterohepatic circulation.
1. Introduction
The human whipworm, Trichuris trichiura, is one of the major Soil
Transmitted Helminths (STHs) and is estimated to infect 465 million
people globally (Pullan et al., 2014), primarily in the tropical and
subtropical areas of the world (Bethony et al., 2006; de Silva et al.,
2003). The current recommendation for control of STHs by the World
Health Organisation (WHO) is the use of an oral single-dose treatment
with albendazole (ABZ) or mebendazole (MBD) which both belong to
the group of benzimidazoles (BZs) (WHO, 2006). However, the eﬃcacy
of a single-dose BZ against Trichuris spp. infection is medium to low in
both humans (Albonico et al., 2003; Keiser and Utzinger, 2008; Knopp
et al., 2010; Olsen et al., 2009; Speich et al., 2012; Steinmann et al.,
2011) and animals (Batte, 1978; Gordon, 1964; Hebden, 1961).
Similarly, anthelmintics from drug classes other than the BZs, such
as ivermectin (IVM) belonging to the macrocyclic lactones (MLs), and
levamisole (LEV), an imidazothiazole derivative, have also shown poor
cure rates (CRs) against human trichuriasis (Albonico et al., 2003;
Belizario et al., 2003; Marti et al., 1996). Also, the amino-acetonitrile
derivative drug, monepantel (MOP) has a questionable eﬀect against
Trichuris spp. in sheep (Sager et al., 2009) and mice (Tritten et al.,
2011).
As a consequence of the extensive use of anthelmintics in livestock,
resistance to the major drug classes has developed rapidly and now has
a large economic impact on livestock production and animal health
worldwide (Kotze et al., 2014). Therefore, emergence of anthelmintic
resistance in human STHs is of major concern (Vercruysse et al., 2011),
particularly with the intended increase of mass drug administration
(MDA) programmes initiated by the WHO (WHO, 2012). The naturally
low susceptibility of Trichuris spp. to a wide range of anthelmintic drugs
leaves only few treatment options in MDA control programmes. If re-
sistance to these drugs develop in an already “low susceptible” parasitic
nematode, such as T. trichiura, the options for future treatments stra-
tegies are limited. Indeed, increase in single nucleotide polymorphisms
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(SNPs) associated with BZ resistance, has recently been reported for T.
trichiura after exposure to ABZ treatment (Diawara et al., 2013). It is
therefore of immediate importance to elucidate the reasons why Tri-
churis spp. infections are notoriously diﬃcult to treat in both animal
and man when administered as single dose.
Adult Trichuris spp. occupy a unique habitat, as the adult worms are
situated partly intracellularly in the caecum and the proximal part of
colon. The thin anterior part of the worm is embedded in the epithelial
layer, whereas the posterior part moves freely in the intestinal lumen
(Bundy and Cooper, 1989; Jenkins, 1970; Tilney et al., 2005). There-
fore, adult Trichuris spp. are potentially exposed to anthelmintic drugs
in both the intestinal content and the mucosa.
In a previous in vivo study, we observed that in pigs infected with T.
suis and orally administered the BZ, fenbendazole (FBZ) at a dose range
of 5 mg/kg, a positive correlation was evident between drug con-
centration in pig blood and within the worms of the FBZ metabolite
oxfendazole (OFZ), and fenbendazole sulfone (FBZSO2) (Hansen et al.,
2014a). These results in pigs suggest that the metabolites enter the
worms from the blood-enterocyte pathway rather than directly from the
gastrointestinal (GI) tract.
The aim of this study was therefore to explore the pathway of OFZ
and metabolites in pigs infected with T. suis by determining the drug
concentrations in worms, caecal mucosal, caecal tissue, caecal content
and plasma, after oral administration of OFZ. For comparison to the in
vivo study, uptake and metabolism of OFZ and metabolites were de-
termined in worms and culture media after in vitro exposure. The T. suis-
pig infection model was chosen as a model for human trichuriasis, as
the pig is considered an appropriate model for drug disposition in hu-
mans (Helke and Swindle, 2013) and T. suis and T. trichiura are closely
related species (Hawash et al., 2015; Nissen et al., 2012).
2. Material and methods
2.1. Ethics statement
The study was performed at the Experimental Animal Unit,
University of Copenhagen, Denmark according to the national regula-
tions of the Danish Animal Inspectorate (permission no. 2015-15-0201-
00760).
2.2. Drugs and chemicals
For the in vitro study, FBZ, OFZ and FBZSO2 were purchased from
Sigma-Aldrich (Schnelldorf, Germany), and stock solutions of the drugs
(10 mM) were prepared in 100% dimethylsulfoxid (DMSO) (Sigma-
Aldrich, Schnelldorf, Germany) and stored at 5 °C until use within 1
week. For the in vivo study, the commercial formulation of OFZ
(Synanthic 9.06%) was purchased from Merial (Lyon, France).
Stock solutions of FBZ, OFZ and FBZSO2 were made in DMSO
(12.7 mM) for the analytical work. Mebendazole was purchased from
Sigma-Aldrich and used as internal standard. All other chemicals used
were of analytical grade.
2.3. Experimental animals and infection
For the in vitro study, 4 castrated male pigs (∼25 kg) were pur-
chased from a Speciﬁc Pathogen Free (SPF) farm (Frenderupgård, Sorø,
DK) with no history of helminth infections for 10 years. For the in vivo
study, 18 castrated male pigs (∼25 kg) were purchased from the same
farm. On the day of arrival, all animals were weighed, identiﬁed by ear
tags, and tested for GI parasite infections using the modiﬁed McMaster
method (Roepstorﬀ et al., 1998). Prior to experimental infection all
animals were acclimatized for a period of minimum 1 week. All pigs
included in the in vitro study, and 15 pigs included in the in vivo study
were experimentally infected with 5000 embryonated eggs of T. suis
(kindly provided by Parasite Technologies A/S, Hørsholm, DK)
administered through a stomach tube. Patency of infection was con-
ﬁrmed by faecal egg count (EPG) on day 47 and 49 post infection (p.i.)
using the modiﬁed McMaster technique. The animals had free access to
water and were fed restrictively with a diet consisting of 75% barley
and 25% supplementary feed (NAG, Helsinge, DK) and were kept at a
light/dark cycle of 12 h/12 h. All animals were euthanized by captive
bolt pistol followed by exsanguination.
2.4. Experimental design
2.4.1. In vitro study
To compare the accumulation of OFZ and its metabolites FBZSO2
and FBZ within T. suis, adult worms were incubated in a ﬁnal drug
concentration of 30 μM in RPMI-1640- medium with DMSO (2% v/v).
For each type of drug, 30 worms were incubated at 38 °C (5% CO2, 21%
O2, 90% relative humidity) for 24 h. This concentration and incubation
time were based on previous ﬁndings in which maximum speciﬁc
binding (Bmax) was reached within 24 h when incubated in a con-
centration of 10 μM of FBZ (Hansen et al., 2014b). The accumulation of
OFZ and FBZSO2 were expected to be lower than FBZ due to their lower
lipophilicity, and since previous studies showed that the highest con-
centration of FBZ soluble at 30 μM, this concentration was chosen
(Hansen et al., 2014b). The level of spontaneous drug oxidation in the
media, and/or the secretion of drug metabolites from the worms into
the media, was determined by measuring the metabolites of the drugs
in which the worms were incubated. All incubations were performed in
triplicates.
2.4.2. In vivo study
On arrival, the 18 animals were randomly allocated into 5 test
groups (group 1–5) and 1 control group with 3 animals in each (n= 3).
Group 1 and 2, group 3 and 4, and group 5, were infected on 3 con-
secutive days, respectively. One control pig was infected on each of
these days. The pigs were infected on 3 consecutive days due to prac-
tical reasons in relation to blood sampling and time of euthanasia. At
day 49 p.i. the animals, fasted overnight, were dosed with OFZ by
stomach tube at a dose rate of 5 mg/kg. Blood samples were obtained
by heparinized Vacutainer tubes (BD Vaccutainer, Kruuse, DK) through
vena jugularis 15, 30, 60, 90 min and 2, 3, 4, 6, 8, 12, 24, 32, and 48 h
post treatment (p.t.) or until euthanasia. The pigs in group 1, 2, 3, 4,
and 5 were euthanized 3, 6, 12, 24 and 48 h p.t., respectively. The
selected times of blood sampling and euthanasia were based on a pre-
vious pharmacokinetic study of OFZ in pigs (Moreno et al., 2012), and
detectable levels of OFZ and FBZSO2 in the caecal content and tissues in
pigs from 3 h p.t. with FBZ (5 mg/kg) (Petersen, 1998).
2.5. Recovery of worms, caecal mucosa, caecal tissue and caecal content
2.5.1. In vitro study
Adult T. suis were collected from the caecum by manual plucking,
and were washed following the washing procedure previously de-
scribed by Hill et al. (1993). In short, the worms were exposed to 4
consecutive washing steps (each 15 min) in 39 °C Hanks Balanced Salt
Solution (HBSS), followed by 4 consecutive washing steps (each
60 min) in 39 °C RPMI-1640 medium. To expose the bacteria to anti-
biotics already during the washing procedure, both the HBSS and RPMI-
1640 medium were supplemented with 1% (v/v) amphotericin B-pe-
nicillin-streptomycin solution (10,000 U/mL penicillin, 10,000 mg/mL
streptomycin, 25 mg/mL amphotericin B) and 0.5% (v/v) gentamicin
(10 mg/mL) (All media, antibiotics and anti-mycotic were purchased
from Life Technologies, Naerum, DK).
2.5.2. In vivo study
For the in vivo study the pigs were immediately eviscerated and li-
gatures were placed at the ileum-caecum junction and the caecum-
colon junction. The caecum and the large intestine were subsequently
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separated from the small intestine.
Caecal content was poured through the caecal-colon opening into a
pre-weighed foil tray, weighed, and immediately placed at 105 °C (to
avoid potential bacterial reduction of FBZ to OFZ) for 20 h to obtain dry
matter. The empty caeca were subsequently opened with scissors and
stretched out using needles to ﬁx the tissue.
From each pig, 40 attached worms were collected from the caecal
wall. If the number of worms was insuﬃcient, worms from the most
proximal part of colon were included. Worms were carefully picked by
hand and washed in 50 mL 38 °C isotonic saline for a maximum of 30 s
by gently inverting the tube and then poured into a petri dish in ap-
proximately 0.5 mL of saline. To remove excess of water, the worms
were brieﬂy dabbed on ﬁlter paper, using curved forceps, before being
transferred into Eppendorf tubes and snap frozen in liquid nitrogen. All
samples were stored at −20 °C until high performance liquid chro-
matography (HPLC) analysis.
Before collecting the whole tissue (i.e. all layers of the caecal wall)
and the mucosa, remnants of worms and caecal content were gently
removed using a wooden spatula. Whole tissue samples (2 × 2 cm)
were cut out at the caecum-colon junction, transferred to 15 mL tubes
and snap frozen in liquid nitrogen.
From each pig, a total of 3 g caecal mucosa was gently scraped of
the remaining caecal wall using a glass slide. To obtain a representative
mucosa sample from the whole caecum, the mucosa was thoroughly
mixed in a petri dish before separated into 15 mL tubes (1.5 g in two
tubes) and frozen in liquid nitrogen. All tissue and mucosa samples
were made in duplicates and stored at −20 °C until HPLC analysis.
2.6. High-performance liquid chromatography analysis (HPLC)
2.6.1. Plasma and worms
Oxfendazole and it's metabolites in worms and plasma were mea-
sured using the HPLC method described for plasma (Petersen and Friis,
2000) with minor modiﬁcations. Plasma was analysed without internal
standard. One mL of plasma was loaded on an activated cartridge (Oasis
HLB, 60 mg, 3 mL). The cartridge was activated with 2 mL methanol
followed by 2 mL of water. The loaded cartridge was washed with 2 mL
5% methanol and allowed to dry under vacuum for 1 min, before
eluting the analyte with 2 mL methanol. The eluate was dried at 37 °C
and the residuum was dissolved in 100 μL 50% methanol. This solution
was centrifuged at 8000 × g before 50 μL were injected into the HPLC-
system. Fenbendazole, OFZ and FBZSO2 were diluted in potassium-
phosphate-buﬀer (0.05 M, pH 7.4) at concentrations of 33.4, 31.7 and
30.2 μM from stock solutions in DMSO, work and plasma standards
were prepared and run in parallel.
Vials with worms were thawed and then dried under phosphorous
pentoxide until constant weight. Each vial with dried worm
(29.3–70.2 mg, equivalent to 20–40 worms) was mixed with 200 μL
0.05 M phosphate buﬀer (pH 7.4) and 200 μL mebendazole (8.5 μM,
internal standard) in 0.05 M phosphate buﬀer (pH 7,4). After gentle
homogenization with plastic pestle, 400 μL 6 M guanidine HCl was
added. The sample was vortexed for 1 min and placed at 20 °C for
15 min before centrifugation at 8000 × g for 10 min. The supernatant
was transferred to a clean tube and an additional 400 μL of 6 M gua-
nidine HCl was added to the sample residue. The procedure was re-
peated and the two supernatants were combined and loaded on acti-
vated cartridge (Oasis HLB, 60 mg, 3 mL) as described above. Standards
in phosphate buﬀer and guanidine HCl were run in parallel.
2.6.2. Caecal mucosa, caecal tissue and caecal content
The procedure for the extraction of OFZ and metabolites from tissue
and mucosa samples were adopted from Wilson et al. (1991). Samples
of 0.5 g tissue/mucosa were added 1800 μL 0.05 M phosphate buﬀer
(pH 7.4) and 200 μL phosphate buﬀer containing mebendazole as in-
ternal standard (33.9 μM). The mixture was homogenised in a plastic
tube using an Ultra Torrex homogeniser. Four hundred μL of 4 M
potassium carbonate and 2 g of sodium sulphate were added and the
tube was shaken at 4 °C in 5 min. The analytes were extracted with
3 × 5 mL ethyl acetate. The ethyl acetate layers were pooled and
evaporated at 50 °C under at stream of air. The residue was dissolved in
5 mL n-hexane. One mL of ethanol: 0.2 N HCl (2:1) was added and the
mixture was shaken. After centrifugation the hexane layer was dis-
carded and the extraction step was repeated with another 5 mL of
hexane. To 750 μL of the ethanol acid layer 2 mL of 2% aqueous po-
tassium bicarbonate solution was added. The entire volume was applied
to an activated cartridge (Oasis HLB, 60 mg, 3 mL) as described above.
For the analysis of the caecum content, dried samples were weighed
in tarred foil trays and grinded. Samples of 100 mg were mixed with
1900 mL of water and 100 μL of phosphate buﬀer (0.05 M pH 7.4)
containing mebendazol (33.9 μM). The extraction procedure was as
described above except that the hexane step was omitted. Standard
curves of OFZ and metabolites in tissue and content were run in par-
allel.
The HPLC system (Waters) was equipped with an autosampler, 2
HPLC pumps, and a UV detector set at 294 nm. Separation of analytes
was accomplished at 30 °C on a X-bridge C18 (5 μ, 15 cm). The mobile
phase consisted of a gradient mixed from acetonitrile and 0.025 M
ammonium acetate (pH 7.2) at a ﬂow rate of 1 mL/min. The proportion
of acetonitrile was 35% acetonitrile for the ﬁrst 4 min, progressing
linearly to 70% at 4.5 min, held constant at 70% until 10 min and
ﬁnally reduced to 35% at 11 min for the remaining run time of 18 min.
Retention times for OFZ, FBZSO2 and FBZ were 3 min, 4.8 min and
11 min, respectively. Ratio of peak area of an analyte to peak area of
internal standard was used to calculate concentration of the analyte.
The method for detecting FBZ, OFZ and FBZSO2 in worms, caecal
mucosa, caecal tissue and caecal content was validated in-house by
evaluating the following parameters: linear range, recovery, matrix
eﬀect, precision, selectivity and limit of quantiﬁcation. The calibration
curves for FBZ were linear between 0.1 and 1 μg loaded on the SPE and
for OFZ and FBZSO2 between 0.05 and 0.5 μg loaded on SPE. The re-
covery of FBZ, OFZ and FBZSO2 was determined by comparing the
responses of matrix standards in the range from 0.05 to 1 μg loaded on
SPE with water standards in the same concentrations. The recovery was
76%, 101% and 75% for FBZ, OFZ and FBZSO2, respectively. No matrix
eﬀect could be demonstrated. The intra-assay and inter-assay varia-
bility were 10% and 12%, respectively. The limit of quantiﬁcation
(LOQ) was 1.5, 0.5 and 0.8 mg/g dry worm for FBZ, OFZ and FBZSO2,
respectively corresponding to 5.3, 1.7 and 2.4 nmol/g dry worm tissue.
Corresponding values for all substances were 0.05 μg/g in tissue and
1.0 μg/g in dried content.
2.6.3. Pharmacokinetics
The plasma concentration was ﬁtted to an open one compartment
model with absorption. The pharmacokinetic variables: area under the
plasma curve versus time (AUC), the concentration maximum (Cmax),
time of Cmax (Tmax) and elimination half-life (T½) was calculated for
OFZ and FBZSO2 using standard equations (Gibaldi and Perrier, 2007).
2.7. Statistical analysis
Drug concentrations of OFZ and FBZSO2 within worms, caecal
mucosa, caecal tissue caecal content, media and plasma are presented
as arithmetic means (± SD). For the in vitro data, the eﬀects of ex-
posure drug (OFZ, FBZSO2 or FBZ) on (1) the total drug uptake, and (2)
the proportion of the total drug uptake corresponding to the same
treatment drug, were tested using a Kruskal-Wallis rank sum test in R
version 3.4.2 (R Core Team, 2017).
Multivariate linear models were used to evaluate the association
between worm drug concentrations and drug concentrations in plasma,
caecal mucosa, caecal tissue & caecal content. The parent drug com-
pound and metabolites were modelled separately. In addition, since the
caecal mucosa is part of the caecal tissue, drug concentrations in the
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caecal mucosa are included in the drug concentrations measured in the
caecal tissue. Therefore, two sets of multivariate linear models were
used: one analysis including explanatory variables of plasma, content
and tissue (Model 1), and a second including explanatory variables of
plasma, content and mucosa (Model 2), in order to simplify inter-
pretation between the highly correlated variables of caecal tissue and
caecal mucosa. Equations for the full models are given below:
Model 1: Wi = β0 + ßP Pi + ßC C1 + ßT Ti + ßPC PiCi + ßPT PiTi + ßCT
CiTi + Ɛi
Model 2: Wi = β0 + ßP Pi + ßC C1 + ßT Mi + ßPC PiCi + ßPM
PiMi + ßCM CiMi + Ɛi
Where β denotes the regression coeﬃcient, Ɛ the residuals and i the ith
observation of drug concentration in: worms (W), plasma (P), caecal
content (C), caecal tissue (T) and mucosa (M).
Within the limits of these full models, a forwards stepwise model
selection algorithm was used to select the best ﬁtting ﬁnal models based
on Akaike's Information Criterion (AIC; Akaike, 1973). Residuals from
the ﬁnal models were assessed for normality by visual inspection. All
models were run in R with stepwise model selection algorithms from
the MASS package version 7.3–47 (Venables and Ripley, 2002).
In order to evaluate the drug pathway from the host into T. suis,
correlations between the host compartments (i.e. plasma, caecal con-
tent, caecal tissue and caecal mucosa) were investigated using
Spearman's rank correlation coeﬃcient (ρ). Substantial and signiﬁcant
correlation between compartments was interpreted as “drug move-
ment” between compartments, with an assumed direction based on
biologically meaningful interpretations of the relative strengths of each
set of correlations. For completeness, simple correlations were also in-
vestigated between concentrations in the worm and each of the four
host compartments using the same method. Pairwise correlation results
were visualised using the ggplot2 package version 2.2.1.9000
(Wickham, 2016) in R.
3. Results
3.1. In vitro study
The in vitro studies were conducted to test whether OFZ, FBZSO2
and FBZ were metabolized in the worms. Moreover, the absorption
“preference” of OFZ in relation to metabolites was evaluated. The up-
take of OFZ, FBZSO2 and FBZ, within T. suis and the drug concentration
in incubation media are given in Table 1. The total drug concentration
within T. suis was higher when exposed to FBZSO2 (79.3 ± 2.6 nmol/g
wet worm tissue) compared to worms exposed to OFZ
(25.6 ± 3.3 nmol/g wet worm tissue) and FBZ (33.2 ± 5.7 nmol/g
wet worm tissue). In addition, FBZSO2 constituted 98.96% of the total
drug concentration in worms when exposed to this metabolite, which
was a higher proportion than OFZ (22.6 ± 2.6 nmol/g worm tissue;
88.3% of total) and FBZ (28.6 ± 5.5 nmol/g worm tissue; 86.2% of
total) after OFZ and FBZ exposure, respectively. The overall eﬀect of
drug was signiﬁcant both in terms of the total drug concentration
(p = 0.039) and metabolite proportion (p = 0.039). The overall con-
centrations of the drug metabolites in the worms and media were low
(Table 1), showing that both drug metabolism by the worms themselves
and spontaneous oxidation of the drug compounds during incubation
were relatively minor. Hence, the drug compound measured within the
worms was predominantly the compound surrounding the worms in
vitro. Interestingly, T. suis seemed to have an absorption “preference” of
FBZSO2 in relation to OFZ and FBZ.
3.2. In vivo study
The concentrations of OFZ and FBZSO2 in T. suis, caecal mucosa,
caecal tissue, caecal content and plasma are shown in Fig. 1a–b. The
concentrations of FBZ in plasma were mostly below quantiﬁcation
level, and examination of the distribution of residuals from the FBZ
model indicated lack of normality. Therefore, Fig. 1c shows only the
FBZ concentrations in T. suis, caecal mucosa, tissue, and content, and
results from the multivariate linear models for the FBZ-data are not
shown. Furthermore, insuﬃcient numbers of worms were obtained
from one animal in group 3 and 4 respectively, hence, the presented
worm-data is based on n = 2 at 12 and 24 h p.t.
It is noteworthy that the drug concentrations of OFZ within the
worms and the plasma of the pigs showed a relatively similar pattern
over the entire sampling period, whereas the similarity in pattern be-
tween worms, tissue and mucosa was only observed at 24 and 48 h p.t.
(Fig. 1a). Also noteworthy is the relatively high peak in OFZ con-
centration 6 h p.t. in content (66.8 ± 37.1 nmol/g wet content) and
mucosa (179.8 ± 45.0 nmol/g wet tissue). This peak was absent in
both worms and plasma, which for comparison, was 15.9 ± 0.7 nmol/
g wet worm tissue and 4.4 ± 0.4 nmol/mL, respectively (Fig. 1a). A
similarity in pattern between FBZSO2 concentration in plasma, tissue
and worms was observed during the whole sampling period, whereas
the similarity in pattern between worms, mucosa and content only was
seen at 12, 24 and 48 h p.t. The FBZSO2 concentrations during the
entire sampling period were higher within the worms compared to
concentrations in plasma, caecal mucosa tissue, and content. At 24 h
p.t. the concentration were in worms 16.6 ± 0.01 (nmol/g wet worm
tissue), in plasma 2.5 ± 0.2 (nmol/mL), in caecal mucosa 2.69 ± 0.2
(nmol/g wet mucosa), in caecal tissue 2.5 ± 0.4 (nmol/g wet tissue),
and in caecal contents 1.6 ± 0.2 (nmol/g wet content).
The worm concentrations of the two remaining compounds (OFZ
and FBZSO2) were analysed using multivariate linear models. For OFZ,
stepwise model selection based on AIC yielded a ﬁnal model including
plasma, tissue, and the interaction of plasma and tissue for Model 1, and
a ﬁnal model including plasma, mucosa, and the interaction of plasma
and mucosa for Model 2. For FBZSO2, a ﬁnal model including only
plasma was obtained for Model 1 and an identical model was obtained
for Model 2. The adjusted R2 measures how much variation in drug
concentration within the worms the model can account for. In the ﬁnal
models R2 was 0.94 for OFZ and 0.88 for FBZSO2 in Model 1, and 0.95
for OFZ and 0.88 for FBZSO2 in Model 2. The ﬁnal model results are
shown in Table 2.
There was a strong and highly signiﬁcant (p < 0.001) positive
association between OFZ concentrations within T. suis and in plasma,
along with a weaker association between OFZ concentrations in caecal
tissue and T. suis. There was also a highly signiﬁcant (p < 0.001)
negative interaction between plasma and caecal tissue concentrations,
Table 1
In vitro drug concentrations within Trichuris suis and media.
Drug in media
(30 μM)
Drug Drug concentration
within T. suis (mean ± SD)
(nmol/g wet worm tissue)
Drug concentration in
media (mean ± SD)
(nmol/mL)
OFZ FBZ 1.7 ± 0.5 < LOD
OFZ 22.6 ± 2.6 –
FBZSO2 1.3 ± 0.3 0.04 ± 0.002
Total 25.6 ± 3.3
FBZSO2 FBZ 0.7 ± 0.8 < LOD
OFZ 0.2 ± 0.02 0.008 ± 0.003
FBZSO2 78.5 ± 1.9 –
Total 79.3 ± 2.6
FBZ FBZ 28.6 ± 5.5 –
OFZ 0.9 ± 0.2 0.008 ± 0.001
FBZSO2 3.7 ± 0.2 0.08 ± 0.012
Total 33.2 ± 5.7
Arithmetic means (± SD, n = 3) of oxfendazole (OFZ), fenbendazole sulfone (FBZSO2)
and fenbendazole (FBZ), and concentrations within Trichuris suis and media after 24 h
exposure to OFZ, FBZSO2 or FBZ (30 μM), respectively.
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indicating that an increase in the tissue concentration of OFZ has a
smaller eﬀect on the concentration within T. suis when the plasma
concentration is high (and vice versa). Very similar results were ob-
tained for Model 2.
For FBZSO2, a highly signiﬁcant (p < 0.001) positive association
was found between concentrations in plasma and T. suis, but based on
AIC there was no signiﬁcant eﬀect of either caecal tissue (Model 1) or
caecal mucosa (Model 2). Caecal content was not included based on AIC
for any of the four models.
The multivariate modelling results indicate that the strongest as-
sociation with drug concentration in T. suis is found with drug con-
centration in plasma. However, based on simple univariate analysis,
there are signiﬁcant correlations between the drug concentrations in T.
suis and each of the four host compartments (plasma is excluded for
FBZ) (Supl. Fig. 1). This is due to the correlation between drug con-
centrations in each of the host compartments (Supl. Fig. 2), which is
likely caused by drug movement between these compartments. In
particular, FBZSO2 and OFZ appear to be highly correlated between
plasma and caecal tissue, and between caecal content and mucosa. In
comparison to oxfendazole, the correlations are generally highest for
FBZSO2, in particular the correlation between plasma and content.
After oral administration of OFZ (5 mg/kg), OFZ and the metabolite
FBZSO2 was detected in plasma as early as 15 min p.t. whereas FBZ
mostly were below detection level. The OFZ-data ﬁtted a one com-
partment model with absorption. The mean (± SD) plasma con-
centration vs. time proﬁles of OFZ and FBZSO2 for pig in group 5, which
were euthanized 48 h p.t., is shown in Fig. 2. The pharmacokinetic
variables of OFZ is presented in Table 3 for pigs in group 5 (mean ±
Fig. 1. Mean (± SD) in vivo concentrations of a) oxfendazole (OFZ), b) fenbendazole
sulfone (FBZSO2) and c) fenbendazole (FBZ) in the worms ( ), plasma ( ), whole caecal
tissue ( ), mucosa ( ) and intestinal caecal content ( ) 3, 6, 12, 24 and 48 h after oral
administration of OFZ (5 mg/kg). For each point in time n = 3, except at 12 and 24 h
where n = 2.
Table 2
Regression coeﬃcients (β), standard errors, F values and p values from the ﬁnal multi-
variate linear regression models describing the association between drug accumulation
within Trichuris suis in vivo and drug concentrations in plasma (Models 1 & 2), caecal
tissue (Model 1 only) and caecal mucosa (Model 2 only). Note that none of the ﬁnal
models included caecal content as an explanatory variable. The F values and p values
presented were obtained from type II analysis-of-variance tables.
β estimate Std. error F value p value
MODEL 1: OFZ
Intercept (β0) 0.76 3.02 – –
Plasma (ßP) 8.50 1.19 43.4 <0.001
Caecal tissue (ßT) 6.73 1.24 8.7 0.012
Plasma x caecal tissue (ßPT) −1.22 0.25 23.5 <0.001
MODEL 2: OFZ
Intercept (β0) 1.47 3.27 – –
Plasma (ßP) 9.58 1.07 69.9 <0.001
Caecal mucosa (ßM) 0.59 0.15 11.2 0.009
Plasma x caecal mucosa (ßPM) −0.12 0.03 11.5 0.008
MODEL 1 & 2: FBZSO2
Intercept (β0) 2.65 2.64 – –
Plasma (ßP) 21.16 2.21 91.5 <0.001
Fig. 2. Oxfendazole ( ) (OFZ) and fenbendazole sulfone ( ) (FBZSO2) plasma con-
centrations (mean ± SD) vs. time curve calculated to the last sampling time 48 h p.t.
after oral administration of OFZ (5 mg/kg).
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SD) and for all pigs (pooled data, group 1–5).
4. Discussion
We have demonstrated that exposure of T. suis in vitro to OFZ,
FBZSO2 or FBZ results in accumulation of the same drug compounds in
which the worms are incubated, without signiﬁcant metabolism of
drugs in the media or T. suis. We therefore presume that the drug
concentrations measured within the worms in vivo, are related to the
drug concentrations surrounding the worms at their predilection site in
the caecum. As the thin anterior part of T. suis is embedded in the
mucosa, and the posterior thicker part is free in the lumen of the
caecum, the worms are exposed to anthelmintic drugs from both the
caecal content and the mucosa in which they are embedded. In this
study, we found that OFZ concentrations within T. suis have a sig-
niﬁcant association with OFZ concentration in plasma, caecal tissue and
caecal mucosa. There was no signiﬁcant eﬀect of caecal content, which
might have suggested that OFZ reaching the worms was absorbed from
the caecal content. A negative interaction between the eﬀects of drug
concentration in the plasma and caecal tissue/mucosa was also found,
which indicates that simultaneously increasing concentrations of drug
in both plasma and caecal tissue/mucosa result in a smaller increase in
concentration within T. suis than would be expected from their in-
dividual eﬀects. However, the OFZ concentration in plasma seems to
have a much stronger eﬀect on the drug concentration within the
worms than either the concentration in caecal tissue/mucosa or the
interaction between drug concentration within the plasma and tissue/
mucosa (Table 2). In addition, the OFZ concentrations in the host
compartments, appeared to be highly correlated between plasma and
caecal tissue, and between caecal content and mucosa. For the former,
we believe that this reﬂects a particularly high level of drug movement
between plasma and tissue. For the later we believe the high correlation
should be interpreted with caution, as the caecal content was removed
from the mucosa using a wooden spatula, thus, minor faecal material
may have been present in the mucosa. Based on our results, we there-
fore suggest that the major drug pathway of OFZ, after oral adminis-
tration and absorption across the GI wall of the pig, is through the
peripheral bloodstream to the capillaries in the submucosa, from where
the drug enter the epithelial layer of the caecum and pass into the
worms. A summary of our results, and a suggested pathway of OFZ from
the pig host into T. suis is depicted in Fig. 3a. The importance of ab-
sorbed OFZ and the maintenance of a therapeutic plasma level has
previously been shown to have a higher eﬃcacy against Haemonchus
contortus and Trichostrongylus colubriformis in sheep as compared to
unabsorbed drug passing down the GI tract (Hennessy and Prichard,
1981). These parasitic nematodes are located in the upper part of the GI
tract (i.e. the abomasum and the small intestine) in contrast to T. suis,
which is located in the hindgut. Our results therefore suggest that OFZ
distributed by the blood also has an eﬀect on the drug level in the
hindgut of the pig, hence within T. suis.
In the multivariate analysis we found that FBZSO2 concentrations
within T. suis only had a signiﬁcant association with FBZSO2 con-
centration in plasma. These results therefore suggest that the major
drug pathway of FBZSO2 is through the peripheral bloodstream.
However, it is interesting that in the simple univariate analysis, corre-
lations between drug concentrations in the host compartments, were
generally highest for FBZSO2, in particular between plasma and con-
tent. The sulfone metabolite was detected in plasma as early as 15 min
p.t. showing a very rapid sulfoxidation of OFZ to FBZSO2. This sulfox-
idation is catalyzed by microsomal enzymes of the cytochrome P450
(CYP) family and the microsomal ﬂavin monooxygenase (MFMO)
system (Gottschall et al., 1990) in the liver of mammals, birds and ﬁsh
(Short et al., 1988), thus, oxidation takes place after absorption from
the GI tract. Oxidation of OFZ to FBZSO2 by the bacterial microﬂora of
the intestinal lumen is less likely to occur due to the low redox potential
of the intestine which favours reduction (Lanusse and Prichard, 1993).
Extensive recycling of FBZ and metabolites (i.e. OFZ and FBZSO2) be-
tween plasma and the GI tract via the enterohepatic circulation and
reabsorption across the GI tract, has previously been reported in ru-
minants (Hennessy et al., 1993; Prichard et al., 1981). It is therefore
likely that this process also occurs in pigs and that the relatively high
correlations between compartments, in particularly between plasma
and content, is due to this recycling process, which potentially could
expose the worms to FBZSO2 in a continuous manner. A summary of our
results, and a suggested pathway of FBZSO2 from the pig host into T.
suis is depicted in Fig. 3b.
In this study the proportion of adsorbed drugs to the particulate
material of the caecal digesta was not determined. As only dissolved
drug is bioavailable to the worms (Hennessy, 1993), the drug con-
centrations exposed to the worms may have been lower than the drug
concentrations measured in the caecal content. However, it is possible
that the proportion of drugs adsorbed to the particulate material of the
digesta, is constant at all sampling times, which in relation to the pat-
tern between drug concentrations in plasma, tissue/mucosa and worms,
therefore will show a similar picture (Fig. 1a–b). Most importantly,
plasma had the highest F values, hence was the major determinant of
the drug levels within the worms. We therefore believe that the re-
lationship between the drug concentrations in the diﬀerent compart-
ments will be similar to what is described in our study.
The main entry route of BZs into nematodes is reported to be by
passive diﬀusion across the cuticle, and the rate of drug transfer across
the cuticle is mainly dependent on the lipophilicity of the drug (Ho
et al., 1990, 1992, Mottier et al., 2003, 2006). Hence, it was expected
that FBZ, the most lipophilic drug, with an octanol-water partition
coeﬃcient of 3.93, would accumulate within T. suis at a higher level
than OFZ (octanol-water partition coeﬃcient of 2.03) (Mottier et al.,
2003) and FBZSO2, which, according to PubChem Substance and
Compound database, CID: 162136, has an octanol-water partition
coeﬃcient of 2.3, (National Center for Biotechnology Information1). It
was therefore surprising that the sulfone metabolite, FBZSO2, was the
drug compound, which accumulated at the highest concentration
within the worms in vitro. In fact, the FBZSO2 concentration was more
than two fold higher than both FBZ and OFZ. The polar surface area of
FBZSO2 is higher (110 A2) (National Center for Biotechnology
Information1) than OFZ (103 A2) (CID: 40854, National Center for
Biotechnology Information2) and FBZ (92.3 A2) (CID: 3334, National
Center for Biotechnology Information3). It is therefore speculated, that
the higher polar surface area of FBZSO2, may have an impact on the
absorption process. Interestingly, similar in vitro results were reported
for T. muris incubated in ABZ, ABZSO and ABZSO2. In this study by
Cowan et al. (2017), ABZSO2 accumulated at a much higher level than
ABZ when incubated in 25 μM for 24 h (i.e. 263 ± 173 for ABZ and
421 ± 171 nmol/10 worms for ABZSO2). In the same study, ABZSO
Table 3
Plasma pharmacokinetic variables (48 h = group 5; Pooled data = groups 1–5) for ox-
fendazole (OFZ) in pigs after a single oral dose of Synanthic® 9.06% (5 mg/kg).
Pharmacokinetic variables 48 h (n = 3)
(mean ± SD)
Pooled data
(mean)
AUC(OXF 0–C last) (nmol h/mL) 82.54 ± 7.96 87.17
Cmax (nmol/mL) 4.16 ± 0.23 3.77
Tmax (h) 4.7 ± 0.94 4.0
ka (h−1) 0.55 ± 0.09 0.52
ke (h−1) 0.056 ± 0.002 0.047
T½ (h) 12.4 ± 0.5 14.8
F/V (kg/L) 0.31 ± 0.03 0.34
AUC(FBZSO2 0–C last) (nmol h/mL) 40.12 ± 6.22 44.61
AUC(FBZ 0–C last) (nmol h/mL) 1.91 ± 1.13 2.26
AUC(0–C last): area under plasma drug concentration vs. time curve calculated to the last
sampling time 48 h p.t.; Cmax: peak plasma concentration; Tmax: time at peak con-
centration; ka: absorption constant; ke: elimination constant; T½: elimination half-life; F/
V: bioavailability in relation to volume of distribution.
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had a tendency of accumulating in T. muris at a higher level than ABZ In
other helminths, such as the nematode Ascaris suum and the trematode
Fasciola hepatica, ABZSO accumulates at a signiﬁcantly lower level than
ABZ when exposed to ABZ or ABZSO (3.7 μM) in vitro for up to 3 h
(Alvarez et al., 2001). Similar, when the cestode Moniezia benedeni is
incubated in FBZ or OFZ (5 μM) for up to 3.5 h, a signiﬁcantly lower
level of OFZ than FBZ accumulates within the worms (Mottier et al.,
2003). Whether the high accumulation level of the sulfone metabolite
FBZSO2 and ABZSO2 in T. suis and T. muris respectively, is due to a
longer incubation time (24 h) as compared to the studies described
above, is yet unknown. However, this study and the study by Cowan
et al., show that Trichuris spp., accumulate the less lipophilic sulfone
metabolites (i.e. FBZSO2 and ABZSO2) at a higher level than the parent
compounds (i.e. FBZ and ABZ) when incubated for 24 h.
As previously mentioned, a higher level of FBZSO2 was measured
within the worms in vivo, as compared to plasma, tissue, mucosa and
content. This was not observed for OFZ, although OFZ was the major
drug compound in plasma and caecal tissue. Our results therefore
suggest that T. suis, also in vivo, may accumulate FBZSO2 at a relatively
higher level than the parent compound OFZ which strongly suggest that
an active drug uptake process may take place within the T. suis.
The bacillary band of Trichuris spp. is situated ventrally on the thin
anterior part of the worm which is embedded in the epithelial cells of
the caecum and proximal colon (Jenkins, 1970, 1969; Lopes Torres
et al., 2013; Lewis G. Tilney et al., 2005). Thus, the bacillary band is in
close proximity to the cytosol of the epithelial cells from where nutrient
and drugs may be absorbed. Whether anthelmintic drugs are able to
enter the worms through the bacillary band is yet unknown, however,
previous studies from our laboratory showed that the bacillary band
indeed has an absorptive function, at least in relation to glucose
(Hansen et al., 2016). It is therefore speculated, that Trichuris spp., in
contrast to other helminth species, may have an absorption preference
of more hydrophilic BZ-metabolites like the sulfones which may enter
the worms through the bacillary band by an active uptake process.
We have administered Synanthic® 9.06% at a dose rate of 5 mg/kg
body weight. In a previous study by Moreno et al. (2012), a dose of
30 mg/kg body weight was administered to pigs of the Peruvian local
ecotypes breed. It appears that in pigs, the plasma AUC is not linear
Fig. 3. Scheme of a) oxfendazole (OFZ) and b) fenbendazole sulfone (FBZSO2) distribution in Trichuris suis and the compartments: plasma, caecal tissue, caecal mucosa and caecal content
of the pig host. Thick black arrows show the compartments involved in drug pathways of OFZ and FBZSO2 from the Model 1 and Model 2 analysis, respectively. Dashed lines indicate
assumed drug pathways between compartments based on the simple univariate analysis. Red arrow indicate suggested pathways of OFZ and FBZSO2. (For interpretation of the references
to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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with this dose since the ﬁgure in our study was 26.03 μg h/mL vs 209.9
in the study by Moreno et al. (2012). This diﬀerence is mainly ascribed
to a faster elimination rate in our study (T½ 12.4 h vs. 21.6 h). The
metabolism of BZs is catalyzed by CYPs (Gottschall et al., 1990), which
expression level is gender age and breed dependent (Helke et al., 2016;
Kojima and Degawa, 2016). In our study, the pigs were castrated males,
18 weeks of age, and crossbreeds of Yorkshire, Landrace and Duroc,
whereas the pigs in the study of Moreno et al., (2012) were males and
females of the Peruvian local ecotypes breed in the age range of 3–6
months. Thus, the faster elimination rate may be due to diﬀerent ex-
perimental conditions such as gender, age and breed. In addition, dif-
ferent types of diet has been shown to aﬀect the plasma pharmacoki-
netic of BZs in pigs (Alvarez et al., 1996), thus, it is possible, that some
of the diﬀerence in AUC may be ascribed to the diﬀerences in diet.
5. Conclusion
Based on our results, we suggest that OFZ reaches T. suis after ab-
sorption from the GI tract and is primarily distributed to the worms by
the systemic circulation-enterocyte pathway, and that FBZSO2 may
reach the worm in a similar manner possibly involving the en-
terohepatic circulation. In contrast to other parasitic helminths, T. suis
seems to have an absorption “preference” of less lipophilic, and higher
polar surface area BZs metabolites, which may be due to the absorptive
function of the bacillary band and its expected function as an external
gut. Explorative drug-absorption studies on the bacillary band may
therefore reveal important implication of this structure, and increase
our understanding of why Trichuris spp. in general are less susceptible
to a broad range of anthelmintic drugs.
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